Five COVID vaccines in Phase III clinical trials: China

Beijing: China has five vaccines for Novel Coronavirus currently undergoing phase III clinical trials in some foreign countries, a Foreign Ministry spokesperson said on Wednesday.

Spokesperson Zhao Lijian told a news briefing that since the outbreak of COVID-19, the Chinese government adopted five technological approaches to develop COVID-19 vaccines, namely inactivated vaccines, adenovirus vector vaccines, recombinant protein vaccines, vaccines using attenuated influenza viruses as vectors, and nucleic acid vaccines.…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.

Comments are closed.